Stockreport

Immune Pharmaceuticals Engages Extera Partners to Pursue Bertilimumab Strategic Transaction

IMMUNE PHARMACEUTICALS INC NE  (IMNP) 
US:NASDAQ Investor Relations: immunepharma.com/investor-relations
PDF FORT LEE, N.J., Dec. 18, 2018 (GLOBE NEWSWIRE) -- Immune Pharmaceuticals, Inc. (OTCQB: IMNP) (“Immune” or “the Company”), a biopharmaceutical company developing novel [Read more]